Cargando…

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study

AIM: The effect of recombinant human thrombopoietin (rhTPO) is largely unknown in lower-risk myelodysplastic syndrome (LR-MDS). This study aimed at investigating the safety and efficacy of rhTPO in patients with LR-MDS. METHODS: LR-MDS patients receiving stanozolol (2 mg, t.i.d.) and supportive care...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuan, Tang, Zengwei, Ji, Jiang, Yang, Chen, Chen, Miao, Han, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581467/ https://www.ncbi.nlm.nih.gov/pubmed/34778037 http://dx.doi.org/10.3389/fonc.2021.721764

Ejemplares similares

Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT
por: Cao, Yigeng, et al.
Publicado: (2022)

Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
por: Cho, Jooyoung, et al.
Publicado: (2018)

Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML
por: Chen, Xiangli, et al.
Publicado: (2023)

A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
por: Zhu, Qiuhua, et al.
Publicado: (2021)

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes
por: Chen, Qiuni, et al.
Publicado: (2022)

Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
por: Mo, Hongnan, et al.
Publicado: (2021)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
por: Spivak, Jerry L., et al.
Publicado: (2021)

Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia
por: Kanaji, Taisuke, et al.
Publicado: (2018)

Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia
por: Li, Yang, et al.
Publicado: (2022)

Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice
por: Eaton, Nathan, et al.
Publicado: (2022)

Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia
por: Tang, Yaqiong, et al.
Publicado: (2018)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
por: Zhang, Mengying, et al.
Publicado: (2023)

The thrombopoietin receptor: revisiting the master regulator of platelet production
por: Hitchcock, Ian S., et al.
Publicado: (2021)

Thrombopoietin participates in platelet activation in COVID-19 patients
por: Lupia, Enrico, et al.
Publicado: (2022)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021)

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review
por: Yang, Yuan, et al.
Publicado: (2021)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

DNA Repair and Cytokines: TGF-β, IL-6, and Thrombopoietin as Different Biomarkers of Radioresistance
por: Centurione, Lucia, et al.
Publicado: (2016)

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
por: Evstatiev, Rayko, et al.
Publicado: (2014)

Thrombopoietin levels in Quebec platelet disorder—Implications for the mechanism of thrombocytopenia
por: Hayward, C. P. M., et al.
Publicado: (2018)

Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
por: Wang, Huaquan, et al.
Publicado: (2015)

Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
por: Gu, Jingli, et al.
Publicado: (2021)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation
por: Wang, Chao, et al.
Publicado: (2015)

Thrombopoietin and collagen in low doses cooperatively induce human platelet activation
por: Doi, Tomoaki, et al.
Publicado: (2022)

Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
por: Lyu, Ning, et al.
Publicado: (2020)

Radiomics for detecting prostate cancer bone metastases invisible in CT: a proof-of-concept study
por: Hinzpeter, Ricarda, et al.
Publicado: (2021)

A proof-of-concept study on endoscopic ultrasound-guided biopsy of detrusor muscle in porcine bladders
por: Teoh, Jeremy Yuen-Chun, et al.
Publicado: (2023)

Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
por: Li, Quanfu, et al.
Publicado: (2021)

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
por: Rauber, Philip, et al.
Publicado: (2018)

Thrombopoietin knock-in augments platelet generation from human embryonic stem cells
por: Zhang, Leisheng, et al.
Publicado: (2018)

Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
por: Bosco, Ornella, et al.
Publicado: (2021)

An Artificial Intelligence-Based Full-Process Solution for Radiotherapy: A Proof of Concept Study on Rectal Cancer
por: Xia, Xiang, et al.
Publicado: (2021)

Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept
por: Macchia, Gabriella, et al.
Publicado: (2022)

Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis
por: Kyrochristos, Ioannis D., et al.
Publicado: (2022)

Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial
por: Wen, Bingbing, et al.
Publicado: (2022)

The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation
por: Hou, Chang, et al.
Publicado: (2021)

The Differential Expression of CD47 may be Related to the Pathogenesis From Myelodysplastic Syndromes to Acute Myeloid Leukemia
por: Yan, Xiao, et al.
Publicado: (2022)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Differential Oxygenation in Tumor Microenvironment Modulates Macrophage and Cancer Cell Crosstalk: Novel Experimental Setting and Proof of Concept
por: Campillo, Noelia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hap02trehi3lb0gfg456neqcb